GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Book to Bill Ratio

Bruker (Bruker) Book to Bill Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bruker Book to Bill Ratio?

Book to Bill Ratio is the ratio of orders received to units billed for a specified period.

The historical rank and industry rank for Bruker's Book to Bill Ratio or its related term are showing as below:

BRKR's Book to Bill Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Book to Bill Ratio only.

Bruker Book to Bill Ratio Historical Data

The historical data trend for Bruker's Book to Bill Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Book to Bill Ratio Chart

Bruker Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Book to Bill Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only

BrukerQuarterly Data
Trend Dec20 Dec21 Dec22 Dec23
Book to Bill Ratio
Get a 7-Day Free Trial Premium Member Only

Competitive Comparison of Bruker's Book to Bill Ratio

For the Medical Devices subindustry, Bruker's Book to Bill Ratio, along with its competitors' market caps and Book to Bill Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bruker  (NAS:BRKR) Book to Bill Ratio Calculation

Book to Bill Ratio is calculated as

Book to Bill Ratio=Orders Received / Orders Shipped

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker  (NAS:BRKR) Book to Bill Ratio Explanation

The book-to-bill ratio is the ratio of orders received to units shipped and billed for a specified period, generally a month or quarter. It is a widely used metric in the technology industry, specifically in the semiconductor equipment sector. The book-to-bill ratio reveals how quickly a business fulfills the demand for its products.

Investors and analysts closely watch this ratio for an indication of the performance and outlook for individual companies and the technology sector as a whole. A ratio above 1.0 implies more orders were received than filled, indicating strong demand, while a ratio below 1.0 implies weaker demand.

Bruker Book to Bill Ratio Related Terms

Thank you for viewing the detailed overview of Bruker's Book to Bill Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bruker (Bruker) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Book to Bill Ratio
Comparable Companies
SWAV PODD GMED BIO PEN MASI GKOS INSP TMDX ITGR ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
BKD:Germany
Address
40 Manning Road, Billerica, MA, USA, 01821
Website
https://www.bruker.com
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Executives
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139